Berlin - Delayed Quote EUR
Editas Medicine Inc (8EM.BE)
1.4525
-0.1110
(-7.10%)
At close: June 2 at 8:01:25 AM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-208,211
-210,284
-132,178
-177,349
-163,803
Investing Cash Flow
223,278
162,146
-3,731
114,068
-54,466
Financing Cash Flow
54,398
56,027
118,039
1,284
282,106
End Cash Position
142,569
135,418
127,529
145,399
207,396
Capital Expenditure
-7,069
-8,826
-4,719
-4,118
-7,977
Issuance of Capital Stock
1,435
0
117,079
0
249,459
Free Cash Flow
-215,280
-219,110
-136,897
-181,467
-171,780
12/31/2021 - 2/5/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IMR.BE AC Immune SA
1.4540
-4.84%
25I.SG ImmuPharma PLC
0.0210
0.00%
600161.SS TIANTAN BIO
19.32
+0.99%
GXE.F Galapagos NV
25.24
+0.32%
9WV.BE Nutriband Inc
5.70
+1.79%
BCX.WA Bioceltix S.A.
104.40
+0.58%
RXK3.MU SELLAS Life Sciences Group Inc
1.4670
-1.81%
ATOS.MX Atossa Therapeutics, Inc.
16.00
0.00%
0M4.F Mersana Therapeutics, Inc.
0.2771
+8.84%
22Z.SG Zealand Pharma A/S
60.04
-1.22%